CVE-2025-43779: CWE-79: Cross-site Scripting in Liferay Portal
A reflected cross-site scripting (XSS) vulnerability in the Liferay Portal 7.4.0 through 7.4.3.112, and Liferay DXP 2024.Q1.1 through 2024.Q1.18 and 7.4 GA through update 92 allows a remote authenticated attacker to inject JavaScript code via _com_liferay_commerce_product_definitions_web_internal_portlet_CPDefinitionsPortlet_productTypeName parameter. This malicious payload is then reflected and executed within the user's browser.
AI Analysis
Technical Summary
CVE-2025-43779 is a reflected Cross-Site Scripting (XSS) vulnerability identified in Liferay Portal versions 7.4.0 through 7.4.3.112 and Liferay DXP versions 2024.Q1.1 through 2024.Q1.18, as well as 7.4 GA through update 92. The vulnerability arises from improper sanitization of the _com_liferay_commerce_product_definitions_web_internal_portlet_CPDefinitionsPortlet_productTypeName parameter, which allows a remote attacker to inject malicious JavaScript code. This injected code is then reflected back and executed within the victim user's browser context. Notably, the vulnerability does not require authentication, user interaction, or privileges, making it accessible to unauthenticated remote attackers. The CVSS 4.0 base score is 6.9, indicating a medium severity level. The attack vector is network-based with low attack complexity and no privileges or user interaction required. The vulnerability impacts confidentiality and integrity to a limited extent, as the reflected XSS can be used to steal session tokens, perform actions on behalf of the user, or redirect users to malicious sites. However, it does not directly affect system availability. No known exploits are currently reported in the wild, and no official patches have been linked yet. The vulnerability falls under CWE-79, which is a common web application security flaw related to improper input validation and output encoding, leading to script injection risks.
Potential Impact
For European organizations using Liferay Portal or Liferay DXP within the affected versions, this vulnerability poses a significant risk to web application security. Exploitation could lead to session hijacking, unauthorized actions performed under the victim's credentials, and potential phishing attacks by injecting malicious scripts. This could result in data leakage, unauthorized access to sensitive information, and reputational damage. Given Liferay's popularity among enterprises for content management and digital experience platforms, especially in sectors like government, finance, and healthcare across Europe, the impact could be substantial. Attackers could target employees or customers via crafted URLs or links, exploiting the reflected XSS to compromise user accounts or implant malware. The lack of required authentication lowers the barrier for attackers, increasing the likelihood of exploitation attempts. While no active exploits are known, the medium severity and ease of exploitation warrant proactive mitigation to prevent potential attacks that could disrupt business operations or lead to regulatory non-compliance under GDPR due to data breaches.
Mitigation Recommendations
European organizations should immediately assess their Liferay Portal and DXP deployments to identify affected versions. Until official patches are released, organizations should implement the following mitigations: 1) Employ Web Application Firewalls (WAFs) with custom rules to detect and block malicious payloads targeting the vulnerable parameter. 2) Apply strict Content Security Policy (CSP) headers to restrict the execution of unauthorized scripts in browsers. 3) Conduct thorough input validation and output encoding on all user-supplied data, especially parameters related to productTypeName, to prevent script injection. 4) Educate users and administrators about the risks of clicking on suspicious links and encourage reporting of unusual behavior. 5) Monitor web server and application logs for unusual requests containing suspicious script patterns targeting the vulnerable parameter. 6) Plan and prioritize patching as soon as Liferay releases official updates addressing this vulnerability. 7) Consider isolating or restricting access to the affected portals if feasible, especially for high-risk user groups. These targeted measures go beyond generic advice by focusing on the specific vulnerable parameter and leveraging layered defenses to reduce attack surface and impact.
Affected Countries
Germany, France, United Kingdom, Netherlands, Italy, Spain, Belgium, Sweden
CVE-2025-43779: CWE-79: Cross-site Scripting in Liferay Portal
Description
A reflected cross-site scripting (XSS) vulnerability in the Liferay Portal 7.4.0 through 7.4.3.112, and Liferay DXP 2024.Q1.1 through 2024.Q1.18 and 7.4 GA through update 92 allows a remote authenticated attacker to inject JavaScript code via _com_liferay_commerce_product_definitions_web_internal_portlet_CPDefinitionsPortlet_productTypeName parameter. This malicious payload is then reflected and executed within the user's browser.
AI-Powered Analysis
Technical Analysis
CVE-2025-43779 is a reflected Cross-Site Scripting (XSS) vulnerability identified in Liferay Portal versions 7.4.0 through 7.4.3.112 and Liferay DXP versions 2024.Q1.1 through 2024.Q1.18, as well as 7.4 GA through update 92. The vulnerability arises from improper sanitization of the _com_liferay_commerce_product_definitions_web_internal_portlet_CPDefinitionsPortlet_productTypeName parameter, which allows a remote attacker to inject malicious JavaScript code. This injected code is then reflected back and executed within the victim user's browser context. Notably, the vulnerability does not require authentication, user interaction, or privileges, making it accessible to unauthenticated remote attackers. The CVSS 4.0 base score is 6.9, indicating a medium severity level. The attack vector is network-based with low attack complexity and no privileges or user interaction required. The vulnerability impacts confidentiality and integrity to a limited extent, as the reflected XSS can be used to steal session tokens, perform actions on behalf of the user, or redirect users to malicious sites. However, it does not directly affect system availability. No known exploits are currently reported in the wild, and no official patches have been linked yet. The vulnerability falls under CWE-79, which is a common web application security flaw related to improper input validation and output encoding, leading to script injection risks.
Potential Impact
For European organizations using Liferay Portal or Liferay DXP within the affected versions, this vulnerability poses a significant risk to web application security. Exploitation could lead to session hijacking, unauthorized actions performed under the victim's credentials, and potential phishing attacks by injecting malicious scripts. This could result in data leakage, unauthorized access to sensitive information, and reputational damage. Given Liferay's popularity among enterprises for content management and digital experience platforms, especially in sectors like government, finance, and healthcare across Europe, the impact could be substantial. Attackers could target employees or customers via crafted URLs or links, exploiting the reflected XSS to compromise user accounts or implant malware. The lack of required authentication lowers the barrier for attackers, increasing the likelihood of exploitation attempts. While no active exploits are known, the medium severity and ease of exploitation warrant proactive mitigation to prevent potential attacks that could disrupt business operations or lead to regulatory non-compliance under GDPR due to data breaches.
Mitigation Recommendations
European organizations should immediately assess their Liferay Portal and DXP deployments to identify affected versions. Until official patches are released, organizations should implement the following mitigations: 1) Employ Web Application Firewalls (WAFs) with custom rules to detect and block malicious payloads targeting the vulnerable parameter. 2) Apply strict Content Security Policy (CSP) headers to restrict the execution of unauthorized scripts in browsers. 3) Conduct thorough input validation and output encoding on all user-supplied data, especially parameters related to productTypeName, to prevent script injection. 4) Educate users and administrators about the risks of clicking on suspicious links and encourage reporting of unusual behavior. 5) Monitor web server and application logs for unusual requests containing suspicious script patterns targeting the vulnerable parameter. 6) Plan and prioritize patching as soon as Liferay releases official updates addressing this vulnerability. 7) Consider isolating or restricting access to the affected portals if feasible, especially for high-risk user groups. These targeted measures go beyond generic advice by focusing on the specific vulnerable parameter and leveraging layered defenses to reduce attack surface and impact.
Affected Countries
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- Liferay
- Date Reserved
- 2025-04-17T10:55:28.238Z
- Cvss Version
- 4.0
- State
- PUBLISHED
Threat ID: 68d34329712f26b964cf395c
Added to database: 9/24/2025, 1:02:33 AM
Last enriched: 9/24/2025, 1:17:27 AM
Last updated: 9/24/2025, 8:11:52 AM
Views: 7
Related Threats
CVE-2025-9031: CWE-208 Observable Timing Discrepancy in DivvyDrive Information Technologies Inc. DivvyDrive Web
MediumCVE-2025-48459: CWE-502 Deserialization of Untrusted Data in Apache Software Foundation Apache IoTDB
HighCVE-2025-48392: DoS Vulnerability in Apache Software Foundation Apache IoTDB
HighCVE-2025-59930
LowCVE-2025-59929
LowActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
External Links
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.